Navigation Links
Torrance Memorial Medical Center Boosts Patient Safety With Expanded Use Of Capnography Technology
Date:3/19/2013

TORRANCE, Calif., March 19, 2013 /PRNewswire/ -- Torrance Memorial Medical Center recently increased patient safety measures by expanding the use of capnography technology to monitor patients using patient controlled analgesia (PCA) pumps to regulate their pain, undergoing procedural sedation and in coronary care after surgery.

Capnography technology measures how effectively patients are breathing and can alert medical caregivers during an occurrence of life-threatening respiratory depression, which can lead to additional complications including cardiopulmonary arrest. By measuring the amount of carbon dioxide (CO2) the patient is exhaling, capnography provides the earliest indication of respiratory depression, enabling medical staff to intervene before serious adverse events happen.

"Torrance Memorial is committed to protecting patient safety while providing the highest quality of care. Our widespread use of capnography to monitor patient respiration underscores this commitment," said Jennifer Stewart , CNS, Patient Safety Officer, Torrance Memorial Medical Center. "We gladly embrace the latest recommendations to provide our patients the safest experience possible."

Several medical associations recently have encouraged hospitals to make more widespread use of capnography technology to protect their patients. The Joint Commission, the Anesthesia Patient Safety Foundation and the Institute for Safe Medication Practices all recommend monitoring exhaled CO2 (i.e. the quality of ventilation) with capnography to detect respiratory depression, which can be life threatening for patients on PCA pumps. These pumps have proven effective in controlling pain and allowing patients to be discharged from the hospital more quickly. However, because the pumps inject micro-doses of narcotics, the technology poses unique risks for patients, according to several healthcare organizations that recommend hospitals take special precautions. Torrance Memorial Medical Center is among the nation's leaders in the early implementation of capnography monitoring to protect patients using PCA pumps.

Additionally, the American Society of Anesthesiologists now requires the use of end-tidal CO2 monitoring as a part of its Standards for Basic Anesthetic Monitoring in procedural sedation.  Section 3.2.4 of the standard states, "During moderate or deep sedation the adequacy of ventilation shall be evaluated by continual observation of qualitative clinical signs and monitoring for the presence of exhaled carbon dioxide unless precluded or invalidated by the nature of the patient, procedure or equipment."

Torrance Memorial Medical Center also follows the American Heart Association guidelines recommending the use of capnography during advanced cardiac life support and pediatric advanced life support.  Its 2010 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care recommend continuous quantitative waveform capnography for intubated patients throughout the peri-arrest period to confirm tracheal tube placement and to monitor cardiopulmonary resuscitation quality and detect return of spontaneous circulation.

"As a magnet facility, we knew a multidisciplinary approach to implementation would be key to our success," said Patrick Moore , RRT, Respiratory Therapy Clinical Educator, Torrance Memorial Medical Center. "A team comprised of anesthesiologists, registered nurses and respiratory therapists worked together, devising an implementation plan. All team members were dedicated to improving patient safety and outcomes for the community we serve."

Torrance Memorial Medical Center chose capnography equipment from Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices.

"We commend Torrance Memorial for being part of a growing number of facilities across the country committed to patient safety through the use of capnography," said Robert J. White , President, Respiratory & Monitoring Solutions, Covidien. "Its decision to monitor patients at risk of respiratory depression with both capnography and oximetry helps protect patients from risk when using state-of-the-art pain management systems."

About Torrance Memorial Medical Center

Founded in 1925 by Jared Sydney and Helena Childs Torrance , Torrance Memorial Medical Center is a locally governed, 401-bed, non-profit medical center established to provide quality healthcare services, predominantly to the residents of the South Bay, Peninsula and Harbor communities. Torrance Memorial seeks to offer the most current and effective medical technologies rendered in a compassionate, caring manner. For more information please visit: www.TorranceMemorial.org.


'/>"/>
SOURCE Torrance Memorial Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Huntington Memorial Hospital Elects Paul Johnson, Deborah Williams to its Board of Directors
2. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
3. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
4. Wyckoff Heights Medical Center Is First New York Hospital to Offer Asthmapolis Mobile Asthma Management Program
5. Varian Medical Systems Schedules Mid-Year Review with Investors in New York
6. Cardinal Health Completes Acquisition Of AssuraMed, Leading Direct-To-Home Medical Supplies Distributor
7. Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines
8. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
9. OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York
10. SonaCare Medical to Introduce Two New HIFU Products at the European Association of Urology (EAU) Congress
11. ESPN Chief Medical Correspondent Joins Orthopaedic Industry Leaders at OrthoTec 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements since 2010 ... agreements entered into by the world,s leading healthcare companies. ... by value - Deals listed by company A-Z, industry ... provides understanding and access to the partnering deals and ... The report provides an analysis of partnering deals. ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... treatments for patients with sleep apnea and TMJ disorders. These conditions are quite ... health. Dr. Rassouli provides personalized care to reduce the risk of these consequences ...
(Date:1/19/2017)... ... 19, 2017 , ... Rountree Brady Insurance Agency, a Savannah ... eastern Georgia, is embarking on a charity effort to raise awareness and gather ... every year than anything else, yet risk factors associated with heart disease are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent distracted ... from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 can ... totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions to ...
(Date:1/19/2017)... ... ... The 21st Century Cures Act’s Impact on Medical Devices:, What You Need ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do manufacturers ... year? , The passage of the act means devicemakers will be scrambling to meet ...
Breaking Medicine News(10 mins):